METAGENOMICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Takeaways from Analyst

Rising investments in metagenomics research by both private and government bodies will drive demand. Pharmaceutical companies are increasingly leveraging metagenomics to discover new drug candidates from uncultured microbes. This will remain a key driver as the market for novel antibiotics grows.

However, technical challenges around DNA extraction from environmental samples and data analysis pose restraints. Standardizing protocols and developing user-friendly analysis tools can help lower these barriers.

North America currently dominates due to extensive R&D spending and presence of leading players. However, Asia Pacific is emerging as the fastest growing region with strong focus on metagenomics in countries like China, India, and South Korea. Improving research infrastructure and funding is expanding regional capacity. Within Asia Pacific, China holds immense potential owing to government initiatives to establish specialized institutes for metagenomics.